drugset
drugset / Trial / NCT04231136

Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy Volunteers

NCT04231136 ↗

Phase 1 Completed 19 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the pharmacodynamics after single oral dosing of tegoprazan, EAPA115 and RAPA115 in healthy volunteers.

Timeline

Start
2020-01-14
Primary completion
2020-07-29
Completion
2020-08-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator EAPA115 Unknown — Oral
Comparator RAPA115 Unknown — Oral
Subject Tegoprazan Other / unclassified 50 mg Oral

Indications

No indication recorded.